Function of Alternative Splicing
Overview
Authors
Affiliations
Almost all polymerase II transcripts undergo alternative pre-mRNA splicing. Here, we review the functions of alternative splicing events that have been experimentally determined. The overall function of alternative splicing is to increase the diversity of mRNAs expressed from the genome. Alternative splicing changes proteins encoded by mRNAs, which has profound functional effects. Experimental analysis of these protein isoforms showed that alternative splicing regulates binding between proteins, between proteins and nucleic acids as well as between proteins and membranes. Alternative splicing regulates the localization of proteins, their enzymatic properties and their interaction with ligands. In most cases, changes caused by individual splicing isoforms are small. However, cells typically coordinate numerous changes in 'splicing programs', which can have strong effects on cell proliferation, cell survival and properties of the nervous system. Due to its widespread usage and molecular versatility, alternative splicing emerges as a central element in gene regulation that interferes with almost every biological function analyzed.
Alternative Splicing as a Modulator of the Interferon-Gamma Pathway.
Suri P, Badalov A, Ruggiu M Cancers (Basel). 2025; 17(4).
PMID: 40002189 PMC: 11853465. DOI: 10.3390/cancers17040594.
Short internal open reading frames repress the translation of N-terminally truncated proteoforms.
Fettig R, Gonda Z, Walter N, Sallmann P, Thanisch C, Winter M EMBO Rep. 2025; .
PMID: 39962229 DOI: 10.1038/s44319-025-00390-z.
Post-transcriptional regulation supports the homeostatic expression of mature RNA.
Su Z, Fang M, Smolnikov A, Vafaee F, Dinger M, Oates E Brief Bioinform. 2025; 26(1).
PMID: 39913622 PMC: 11801271. DOI: 10.1093/bib/bbaf027.
RNA Metabolism and the Role of Small RNAs in Regulating Multiple Aspects of RNA Metabolism.
Dawar P, Adhikari I, Mandal S, Jayee B Noncoding RNA. 2025; 11(1.
PMID: 39846679 PMC: 11755482. DOI: 10.3390/ncrna11010001.
Identifying Strong Neoantigen MHC-I/II Binding Candidates for Targeted Immunotherapy with SINE.
Bendik J, Castro A, Califano J, Carter H, Guo T Int J Mol Sci. 2025; 26(1.
PMID: 39796063 PMC: 11720059. DOI: 10.3390/ijms26010205.